ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,209,952 | -52.1% | 791,200 | -45.8% | 0.04% | -53.4% |
| Q2 2023 | $29,694,549 | -18.8% | 1,459,909 | -13.2% | 0.09% | -22.1% |
| Q1 2023 | $36,581,759 | -44.4% | 1,681,147 | -20.9% | 0.11% | -49.6% |
| Q4 2022 | $65,828,958 | +2.2% | 2,124,200 | -15.9% | 0.22% | -12.8% |
| Q3 2022 | $64,443,000 | +272.7% | 2,526,200 | +196.6% | 0.26% | +252.1% |
| Q2 2022 | $17,292,000 | -47.0% | 851,800 | -35.4% | 0.07% | -43.4% |
| Q1 2022 | $32,597,000 | +264.8% | 1,317,600 | +412.4% | 0.13% | +258.3% |
| Q4 2021 | $8,936,000 | -45.3% | 257,145 | -66.2% | 0.04% | -55.0% |
| Q4 2020 | $16,346,000 | +247.0% | 760,300 | +260.5% | 0.08% | +158.1% |
| Q2 2020 | $4,711,000 | +1019.0% | 210,886 | +714.2% | 0.03% | +1450.0% |
| Q4 2019 | $421,000 | -82.8% | 25,900 | -22.9% | 0.00% | -81.8% |
| Q1 2019 | $2,454,000 | +23.0% | 33,600 | +68.0% | 0.01% | +37.5% |
| Q3 2018 | $1,995,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |